Skip to navigation Skip to content

Growth hormone deficiency – childhood onset or late onset Program in Pharmaceutical Benefits Scheme (PBS) 012-18112104

Expand/Collapse all sectionsExpand all


This document outlines details of PBS-subsidised somatropin for patients with childhood onset or late onset of severe growth hormone deficiency, previously known as ‘adult growth hormone deficiency (AGHR)’.

Severe growth hormone deficiency and listing dates

Severe growth hormone deficiency is a condition where the body is unable to produce enough hormone which impairs the growth and development of adults.

Listing date: somatropin - 1 December 2018

See Written Authority Required Drugs for more details.

Treatment specifics

Somatropin is not PBS-subsidised for patients with Prader-Willi Syndrome aged 18 years or older without a documented childhood-onset growth hormone deficiency.

Enquiries

Transfer enquiries about prescription arrangements to PBS Complex Drugs Programs and choose the option relevant to the condition treated.

The Resources page contains:

  • application forms
  • contact details
  • restriction and item codes
  • the PBS schedule
  • Services Australia website link

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System)

Process telephone Authority approval application

Processing and National Demand Allocation (PaNDA)

Processing Complex Authority Required Listings

Processing Written Authority requests

Written Authority Required Drugs